You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Multiple sclerosis

Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis

  • Technology appraisal guidance
  • Reference number: TA254
  • Published:  25 April 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Multiple sclerosis (relapsing-remitting) - fingolimod: comments on the ACD received from the public through the NICE website

Multiple sclerosis (relapsing-remitting) - fingolimod: comments on the ACD received from the public through the NICE website Multiple sclerosis (relapsing-remitting) - fingolimod: comments on the ACD received from the public through the NICE website
16 March 2012
(250.89 Kb 13 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 15 March 2012

Back to top